Evaluation of the pol/S Gene Overlapping Mutations in Chronic Hepatitis B Patients in Northern Cyprus

Ahn SH, Kim DH, Lee AR, Kim BK, Park YK, Park ES, Ahn SH, Shin GC, Park S, Kang HS, et al. Substitution at rt269 in hepatitis B virus polymerase Is a compensatory mutation associated with multi-drug resistance. PLoS One. 2015;10(8):e0136728. https://doi.org/10.1371/journal.pone.0136728AhnSHKimDHLeeARKimBKParkYKParkESAhnSHShinGCParkSKangHSet alSubstitution at rt269 in hepatitis B virus polymerase Is a compensatory mutation associated with multi-drug resistance. PLoS One. 2015;10(8):e0136728. https://doi.org/10.1371/journal.pone.013672810.1371/journal.pone.0136728455617326322642Search in Google Scholar

Altindïş M, Aslan FG, Köroğlu M, Eren A, Demïr L, Uslan Mİ, Aslan S, Özdemïr M, Baykan M. Hepatitis B virus carrying drug resistance compensatory mutations in chronically infected treatment naïve patients. Viral Hepatit Dergisi. 2016;22(3):103–107. https://doi.org/10.4274/vhd.07830AltindïşMAslanFGKöroğluMErenADemïrLUslanMİAslanSÖzdemïrMBaykanMHepatitis B virus carrying drug resistance compensatory mutations in chronically infected treatment naïve patients. Viral Hepatit Dergisi. 2016;22(3):103–107. https://doi.org/10.4274/vhd.0783010.4274/vhd.07830Search in Google Scholar

Altindis M, Yilmaz S, Dikengil T, Acemoglu H, Hosoglu S. Serop-revalence and genotyping of hepatitis B, hepatitis C and HIV among healthy population and Turkish soldiers in Northern Cyprus. World J Gastroenterol. 2006;12(42):6792–6796. https://doi.org/10.3748/wjg.v12.i42.6792AltindisMYilmazSDikengilTAcemogluHHosogluSSerop-revalence and genotyping of hepatitis B, hepatitis C and HIV among healthy population and Turkish soldiers in Northern Cyprus. World J Gastroenterol. 2006;12(42):6792–6796. https://doi.org/10.3748/wjg.v12.i42.679210.3748/wjg.v12.i42.6792408743317106927Search in Google Scholar

Arikan A, Şanlidağ T, Süer K, Sayan M, Akçali S, Güler E. [Molecular epidemiology of hepatitis B virus in Northern Cyprus] (in Turkish). Mikrobiyol Bul. 2016;50(1):86–93. https://doi.org/10.5578/mb.10292ArikanAŞanlidağTSüerKSayanMAkçaliSGülerE[Molecular epidemiology of hepatitis B virus in Northern Cyprus] (in Turkish). Mikrobiyol Bul.2016;50(1):86–93. https://doi.org/10.5578/mb.1029210.5578/mb.1029227058332Search in Google Scholar

Asan A, Sayan M, Akhan S, Tekin Koruk S, Aygen B, Sirmatel F, Eraksoy H, Tuna N, Köse S, Kaya A, et al. Molecular characterization of drug resistance in hepatitis B viruses isolated from patients with chronical infection in Turkey. Hepat Mon. 2018;18(1):e12472. https://doi.org/10.5812/hepatmon.12472AsanASayanMAkhanSTekin KorukSAygenBSirmatelFEraksoyHTunaNKöseSKayaAet alMolecular characterization of drug resistance in hepatitis B viruses isolated from patients with chronical infection in Turkey. Hepat Mon.2018;18(1):e12472. https://doi.org/10.5812/hepatmon.1247210.5812/hepatmon.12472Search in Google Scholar

Avellón A, Echevarria JM. Frequency of hepatitis B virus ‘a’ determinant variants in unselected Spanish chronic carriers. J Med Virol. 2006;78(1):24–36. https://doi.org/10.1002/jmv.20516AvellónAEchevarriaJMFrequency of hepatitis B virus ‘a’ determinant variants in unselected Spanish chronic carriers. J Med Virol.2006;78(1):24–36. https://doi.org/10.1002/jmv.2051610.1002/jmv.2051616299725Search in Google Scholar

Bottecchia M, Barcaiu HS, Lewis-Ximenez LL, da Silva e Mouta Junior S, de Moraes MTB. Monitoring the emergence of HBV resistance mutations by HBV-RNA pyrosequencing. Braz J Infect Dis. 2016;20(2):216–217. https://doi.org/10.1016/j.bjid.2015.11.004BottecchiaMBarcaiuHSLewis-XimenezLLda Silva e Mouta JuniorSde MoraesMTBMonitoring the emergence of HBV resistance mutations by HBV-RNA pyrosequencing. Braz J Infect Dis. 2016;20(2):216–217. https://doi.org/10.1016/j.bjid.2015.11.00410.1016/j.bjid.2015.11.00426748231Search in Google Scholar

Caligiuri P, Cerruti R, Icardi G, Bruzzone B. Overview of hepatitis B virus mutations and their implications in the management of infection. World J Gastroenterol. 2016;22(1):145–154. https://doi.org/10.3748/wjg.v22.i1.145CaligiuriPCerrutiRIcardiGBruzzoneBOverview of hepatitis B virus mutations and their implications in the management of infection. World J Gastroenterol. 2016;22(1):145–154. https://doi.org/10.3748/wjg.v22.i1.14510.3748/wjg.v22.i1.145469848126755866Search in Google Scholar

Choi YM, Lee SY, Kim BJ. Naturally occurring hepatitis B virus reverse transcriptase mutations related to potential antiviral drug resistance and liver disease progression. World J Gastroenterol. 2018;24(16):1708–1724. https://doi.org/10.3748/wjg.v24.i16.1708ChoiYMLeeSYKimBJNaturally occurring hepatitis B virus reverse transcriptase mutations related to potential antiviral drug resistance and liver disease progression. World J Gastroenterol. 2018;24(16):1708–1724. https://doi.org/10.3748/wjg.v24.i16.170810.3748/wjg.v24.i16.1708592299129713126Search in Google Scholar

Guler E, Suer K, Arikan A, Guvenir M, Sanlidag T. Seroprevelance of Hepatitis B Virus, Hepatitits C Virus and Human Immunodeficiency Virus in Northern Cyprus. Bakirkoy Med J. 2018;14:332–338.GulerESuerKArikanAGuvenirMSanlidagTSeroprevelance of Hepatitis B Virus, Hepatitits C Virus and Human Immunodeficiency Virus in Northern Cyprus. Bakirkoy Med J. 2018;14:332–338.10.4274/BTDMJB.20170503074555Search in Google Scholar

Gürsoy NC, Otlu B, Yakupogulları Y, Yener Ö, Bayındır Y, Harputluoglu M, Tekerekoglu MS. Nucleos(t)ide resistance mutations in chronic HBV patients with treatment failure. Türk Mikrobiyoloji Cemiyeti Dergisi. 2019;49(1):41–46. https://doi.org/10.5222/TMCD.2019.041GürsoyNCOtluBYakupogullarıYYenerÖBayındırYHarputluogluMTekerekogluMSNucleos(t)ide resistance mutations in chronic HBV patients with treatment failure. Türk Mikrobiyoloji Cemiyeti Dergisi. 2019;49(1):41–46. https://doi.org/10.5222/TMCD.2019.04110.5222/TMCD.2019.041Search in Google Scholar

Lapiński TW, Parfieniuk-Kowerda A, Trzos A, Jaroszewicz J, Kowalczuk O, Nikliński J, Flisiak R. HBV mutations associated with lamivudine therapy. Przegl Epidemiol. 2013;67:611–616.LapińskiTWParfieniuk-KowerdaATrzosAJaroszewiczJKowalczukONiklińskiJFlisiakRHBV mutations associated with lamivudine therapy. Przegl Epidemiol. 2013;67:611–616.Search in Google Scholar

Lazarevic I. Clinical implications of hepatitis B virus mutations: recent advances. World J Gastroenterol. 2014;20(24):7653–7664. https://doi.org/10.3748/wjg.v20.i24.7653LazarevicIClinical implications of hepatitis B virus mutations: recent advances. World J Gastroenterol. 2014;20(24):7653–7664. https://doi.org/10.3748/wjg.v20.i24.765310.3748/wjg.v20.i24.7653406929424976703Search in Google Scholar

Lin CL, Chien RN, Hu CC, Lai MW, Yeh CT. Identification of hepatitis B virus rtS117F substitution as a compensatory mutation for rtM204I during lamivudine therapy. J Antimicrob Chemother. 2012;67(1):39–48. https://doi.org/10.1093/jac/dkr416LinCLChienRNHuCCLaiMWYehCTIdentification of hepatitis B virus rtS117F substitution as a compensatory mutation for rtM204I during lamivudine therapy. J Antimicrob Chemother. 2012;67(1):39–48. https://doi.org/10.1093/jac/dkr41610.1093/jac/dkr41622001270Search in Google Scholar

Mahmood M, Anwar MA. Analysis of resistant mutations in reverse transcriptase domain of hepatitis B virus from patients from Islamabad, Pakistan. J Unexplored Med Data. 2017;2(2):60–64. https://doi.org/10.20517/2572-8180.2017.13MahmoodMAnwarMAAnalysis of resistant mutations in reverse transcriptase domain of hepatitis B virus from patients from Islamabad, Pakistan. J Unexplored Med Data. 2017;2(2):60–64. https://doi.org/10.20517/2572-8180.2017.1310.20517/2572-8180.2017.13Search in Google Scholar

Ozguler M, Sayan M. Could resistant and escape variants of hepatitis B virus be a problem in the future? Future Virol. 2018;13(3):171–179. https://doi.org/10.2217/fvl-2017-0144OzgulerMSayanMCould resistant and escape variants of hepatitis B virus be a problem in the future?Future Virol. 2018;13(3):171–179. https://doi.org/10.2217/fvl-2017-014410.2217/fvl-2017-0144Search in Google Scholar

Ozguler M, Sayan M. Growing threat: vaccine escape mutant hepatitis B viruses. ARC J of Immunology and Vaccines. 2016;1(1):9–17.OzgulerMSayanMGrowing threat: vaccine escape mutant hepatitis B viruses. ARC J of Immunology and Vaccines. 2016;1(1):9–17.Search in Google Scholar

Rugieri Pacheco S, Magalhães Andrade dos Santos MI, Stocker A, Sant’Anna Zarife MA, Schinoni MI, Paraná R, Galvao dos Reis M, Kalabric Silva L. Genotyping of HBV and tracking of resistance mutations in treatment-naïve patients with chronic hepatitis B. Infect Drug Resist. 2017;10:201–207. https://doi.org/10.2147/IDR.S135420Rugieri PachecoSMagalhães Andrade dos SantosMIStockerASant’Anna ZarifeMASchinoniMIParanáRGalvao dos ReisMKalabric SilvaLGenotyping of HBV and tracking of resistance mutations in treatment-naïve patients with chronic hepatitis B. Infect Drug Resist. 2017;10:201–207. https://doi.org/10.2147/IDR.S13542010.2147/IDR.S135420550349928740410Search in Google Scholar

Saran B, Tüzüner U, Feyzïoğlu B, Özdemïr M, Baykan M. Determination of resistance mutation in chronic Hepatitis B patients using antiviral drugs at our hospital. Viral Hepatit Dergisi. 2017;23(1):30–33. https://doi.org/10.4274/vhd.38257SaranBTüzünerUFeyzïoğluBÖzdemïrMBaykanMDetermination of resistance mutation in chronic Hepatitis B patients using antiviral drugs at our hospital. Viral Hepatit Dergisi. 2017;23(1):30–33. https://doi.org/10.4274/vhd.3825710.4274/vhd.38257Search in Google Scholar

Sayan M, Buğdaci MS. [HBV vaccine escape mutations in a chronic hepatitis B patient treated with nucleos(t)ide analogues] (in Turkish). Mikrobiyol Bul. 2013;47(3):544–549. https://doi.org/10.5578/mb.5442SayanMBuğdaciMS[HBV vaccine escape mutations in a chronic hepatitis B patient treated with nucleos(t)ide analogues] (in Turkish). Mikrobiyol Bul.2013;47(3):544–549. https://doi.org/10.5578/mb.544210.5578/mb.544223971933Search in Google Scholar

Sayan M, Cavdar C, Dogan C. Naturally occurring polymerase and surface gene variants of hepatitis B virus in Turkish hemodialysis patients with chronic hepatitis B. Jpn J Infect Dis. 2012;65(6):495–501. https://doi.org/10.7883/yoken.65.495SayanMCavdarCDoganCNaturally occurring polymerase and surface gene variants of hepatitis B virus in Turkish hemodialysis patients with chronic hepatitis B. Jpn J Infect Dis.2012;65(6):495–501. https://doi.org/10.7883/yoken.65.49510.7883/yoken.65.49523183201Search in Google Scholar

Sayan M, Hulagu S, Karatayli SC. Multidrug-resistant hepatitis B virus strain in a chronic Turkish patient. Hepat Mon. 2010a Spring;10(2):141–146.SayanMHulaguSKaratayliSCMultidrug-resistant hepatitis B virus strain in a chronic Turkish patient. Hepat Mon.2010a Spring;10(2):141–146.Search in Google Scholar

Sayan M, Şentürk Ö, Akhan SÇ, Hülagü S, Çekmen MB. Monitoring of hepatitis B virus surface antigen escape mutations and concomitantly nucleos(t)ide analog resistance mutations in Turkish patients with chronic hepatitis B. Int J Infect Dis. 2010b; 14 Suppl 3:e136–e141. https://doi.org/10.1016/j.ijid.2009.11.039SayanMŞentürkÖAkhanSÇHülagüSÇekmenMBMonitoring of hepatitis B virus surface antigen escape mutations and concomitantly nucleos(t)ide analog resistance mutations in Turkish patients with chronic hepatitis B. Int J Infect Dis. 2010b; 14Suppl 3:e136–e141. https://doi.org/10.1016/j.ijid.2009.11.03910.1016/j.ijid.2009.11.03920382061Search in Google Scholar

Shaw T, Bartholomeusz A, Locarnini S. HBV drug resistance: Mechanisms, detection and interpretation. J Hepatol. 2006;44(3): 593–606. https://doi.org/10.1016/j.jhep.2006.01.001ShawTBartholomeuszALocarniniSHBV drug resistance: Mechanisms, detection and interpretation. J Hepatol.2006;44(3): 593–606. https://doi.org/10.1016/j.jhep.2006.01.00110.1016/j.jhep.2006.01.00116455151Search in Google Scholar

Sheldon J, Soriano V. Hepatitis B virus escape mutants induced by antiviral therapy. J Antimicrob Chemother. 2008;61(4):766–768. https://doi.org/10.1093/jac/dkn014SheldonJSorianoVHepatitis B virus escape mutants induced by antiviral therapy. J Antimicrob Chemother. 2008;61(4):766–768. https://doi.org/10.1093/jac/dkn01410.1093/jac/dkn01418218641Search in Google Scholar

Simon B, Kundi M, Puchhammer E. Analysis of mutations in the S gene of hepatitis B virus strains in patients with chronic infection by online bioinformatics tools. J Clin Microbiol. 2013;51(1):163–168. https://doi.org/10.1128/JCM.01630-12SimonBKundiMPuchhammerEAnalysis of mutations in the S gene of hepatitis B virus strains in patients with chronic infection by online bioinformatics tools. J Clin Microbiol.2013;51(1):163–168. https://doi.org/10.1128/JCM.01630-1210.1128/JCM.01630-12353621523115258Search in Google Scholar

Suer HK, Guvenir M, Guler E, Diktas H. Evaluation of HBsAg, anti-HCV, anti-HIV and syphilis test results among the blood donors admitted to the Near East University Hospital in Turkish Republic of Northern Cyprus. Klimik Dergisi/Klimik Journal. 2014; 25(3):99–102. https://doi.org/10.5152/kd.2012.28SuerHKGuvenirMGulerEDiktasHEvaluation of HBsAg, anti-HCV, anti-HIV and syphilis test results among the blood donors admitted to the Near East University Hospital in Turkish Republic of Northern Cyprus. Klimik Dergisi/Klimik Journal. 2014; 25(3):99–102. https://doi.org/10.5152/kd.2012.2810.5152/kd.2012.28Search in Google Scholar

Sun M, Tan G, Song J, Wang J, Wu X. Profile of HBV polymerase gene mutations during entecavir treatment in patients with chronic hepatitis B. Clin Res Hepatol Gastroenterol. 2016;40(5):590–596. https://doi.org/10.1016/j.clinre.2016.02.005SunMTanGSongJWangJWuXProfile of HBV polymerase gene mutations during entecavir treatment in patients with chronic hepatitis B. Clin Res Hepatol Gastroenterol. 2016;40(5):590–596. https://doi.org/10.1016/j.clinre.2016.02.00510.1016/j.clinre.2016.02.00527016894Search in Google Scholar

Tang LSY, Covert E, Wilson E, Kottilil S. Chronic Hepatitis B Infection. JAMA. 2018;319(17):1802–1813. https://doi.org/10.1001/jama.2018.3795TangLSYCovertEWilsonEKottililSChronic Hepatitis B Infection. JAMA. 2018;319(17):1802–1813. https://doi.org/10.1001/jama.2018.379510.1001/jama.2018.379529715359Search in Google Scholar

Tezcan S, Ülger M, Üçbïlek E, Aslan G, Serïn MS, Sezgïn O, Delïalïoğlu N, Altintaş E, Helvaci İ, Emekdaş G. [Characterization of basal core promoter/precore gene mutations in chronically infected patients with hepatitis B virus genotype D in Mersin Province, Turkey] (in Turkish). Mikrobiyol Bul. 2015;49(3):377–392. https://doi.org/10.5578/mb.9479TezcanSÜlgerMÜçbïlekEAslanGSerïnMSSezgïnODelïalïoğluNAltintaşEHelvaciİEmekdaşG[Characterization of basal core promoter/precore gene mutations in chronically infected patients with hepatitis B virus genotype D in Mersin Province, Turkey] (in Turkish). Mikrobiyol Bul.2015;49(3):377–392. https://doi.org/10.5578/mb.947910.5578/mb.947926313279Search in Google Scholar

Wang J, Zhu B, Lu M, Yang D. Hepatitis B virus preS/S gene mutations and their clinical implications. Ann Blood. 2017;2(17):17. https://doi.org/10.21037/aob.2017.10.01WangJZhuBLuMYangDHepatitis B virus preS/S gene mutations and their clinical implications. Ann Blood. 2017;2(17):17. https://doi.org/10.21037/aob.2017.10.0110.21037/aob.2017.10.01Search in Google Scholar

Ward H, Tang L, Poonia B, Kottilil S. Treatment of hepatitis B virus: an update. Future Microbiol. 2016;11(12):1581–1597. https://doi.org/10.2217/fmb-2016-0128WardHTangLPooniaBKottililSTreatment of hepatitis B virus: an update. Future Microbiol.2016;11(12):1581–1597. https://doi.org/10.2217/fmb-2016-012810.2217/fmb-2016-0128554977527855500Search in Google Scholar

WHO. Key Facts Sheet [Internet]. Geneva (Switzerland): World Health Organization; 2018 [cited 2018 July]. Available from: https://www.who.int/en/news-room/fact-sheets/detail/hepatitis-bWHO. Key Facts Sheet [Internet]. Geneva (Switzerland): World Health Organization; 2018 [cited 2018 July]. Available from: https://www.who.int/en/news-room/fact-sheets/detail/hepatitis-bSearch in Google Scholar

Yano Y, Azuma T, Hayashi Y. Variations and mutations in the hepatitis B virus genome and their associations with clinical characteristics. World J Hepatol. 2015;7(3):583–592. https://doi.org/10.4254/wjh.v7.i3.583YanoYAzumaTHayashiYVariations and mutations in the hepatitis B virus genome and their associations with clinical characteristics. World J Hepatol.2015;7(3):583–592. https://doi.org/10.4254/wjh.v7.i3.58310.4254/wjh.v7.i3.583438118125848482Search in Google Scholar

Zaaijer HL, van Hemert FJ, Koppelman MH, Lukashov VV. Independent evolution of overlapping polymerase and surface protein genes of hepatitis B virus. J Gen Virol. 2007;88(8):2137–2143. https://doi.org/10.1099/vir.0.82906-0ZaaijerHLvan HemertFJKoppelmanMHLukashovVVIndependent evolution of overlapping polymerase and surface protein genes of hepatitis B virus. J Gen Virol.2007;88(8):2137–2143. https://doi.org/10.1099/vir.0.82906-010.1099/vir.0.82906-017622615Search in Google Scholar

Zhao Y, Wu J, Sun L, Liu G, Li B, Zheng Y, Li X, Tao J. Prevalence of mutations in HBV DNA polymerase gene associated with nucleos(t)ide resistance in treatment-naive patients with Chronic Hepatitis B in Central China. Braz J Infect Dis. 2016;20(2):173–178. https://doi.org/10.1016/j.bjid.2015.12.006ZhaoYWuJSunLLiuGLiBZhengYLiXTaoJPrevalence of mutations in HBV DNA polymerase gene associated with nucleos(t)ide resistance in treatment-naive patients with Chronic Hepatitis B in Central China. Braz J Infect Dis.2016;20(2):173–178. https://doi.org/10.1016/j.bjid.2015.12.00610.1016/j.bjid.2015.12.00626876337Search in Google Scholar